Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.
Drug Test Anal September 2, 2013 DOI: 10.1002/dta.1522 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractA case of severe intoxication with the synthetic hallucinogen 25B-NBOMe is reported. High performance liquid chromatography with tandem mass spectrometry was used to measure the compound in serum and urine. The method enabled detection and quantification of 25B-NBOMe, confirming its presence in biological samples from the intoxicated individual.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | One severely intoxicated individual |
| Key finding | 25B-NBOMe was detected and quantified in serum and urine using HPLC-MS/MS in a case of severe intoxication. |
Abstract
Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.